JAMA+ Women’s Health: September 22, 2026

Trouble viewing this email? Read it Online

This week's JAMA+ Women's Health features four Original Investigations. In JAMA, a randomized trial found that intrauterine mepivacaine reduced pain during IUD placement, while another study linked adoption of adjunctive azithromycin for unscheduled cesarean delivery with fewer postpartum infections. JAMA Internal Medicine research examined menopausal hormone therapy and cardiovascular risk in midlife women with vasomotor symptoms, and a JAMA Network Open meta-analysis linked intimate partner violence against women with greater mortality among children younger than 5 years. Also included are an audio episode on AI-enabled drug safety in pregnancy and a featured video examining the association between GLP-1 receptor agonist use and reduced risk of several cancers among adults with obesity.

Explore the latest curated research, commentary, and multimedia from JAMA+ Women's Health in the featured articles below.